Rallybio Corp (RLYB): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Rallybio Corp (RLYB) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 8, 2026, Rallybio Corporation (Rallybio) announced that Jonathan Lieber, Rallybio’s Chief Financial Officer,
How this was made
The 30-second read
Why it matters
The filing provides the first public details on the CFO's transition, which may influence short‑term sentiment but is unlikely to cause a large price move.
Market read
Executive compensation change is a modest corporate‑action news item for a micro‑cap; relevance is limited to investors tracking the merger.
What to watch
Severance terms and the part‑time arrangement could affect post‑merger integration costs.
Background
Rallybio Corp filed an SEC Form 8‑K reporting a change in CFO employment status and compensation ahead of its pending merger with Avenzo Therapeutics.
Ticker impact
CFO Jonathan Lieber will shift to part‑time status, receive a $420,000 base salary and lose his annual bonus eligibility, with severance tied to the pending merger with Avenzo Therapeutics.
Potential modest downside pressure until merger closes, limited upside.
Executive compensation adjustments are material for a micro‑cap but unlikely to move the stock dramatically without additional merger news.
Market effects
Limited impact on the broader biotech sector; the filing is company‑specific.
No discernible effect on regional markets.
Minimal global relevance.
Counterpoint
The CFO transition could be a sign of internal disagreements that may delay the merger.
Key entities
- companyRallybio Corp
Biotech firm filing the 8‑K.
- companyAvenzo Therapeutics, Inc.
Merger partner.
- personJonathan Lieber
Chief Financial Officer of Rallybio.
